The 2019 Annual Report to Congress covers an array of topics including U.S.-China trade tensions, U.S. reliance on Chinese pharmaceuticals, China's global military ambitions, and U.S.-China competition in critical emerging technologies.
The U.S.-China Economic and Security Review Commission invites submission of proposals to provide a one-time unclassified report on developments in China’s military and dual-use logistics capabilities to support expeditionary operations beyond China’s borders.
The hearing will review key developments in the U.S.-China relationship in 2019. Panel 1 will evaluate developments in China’s political economy and the impact of U.S.-China trade frictions on the Chinese economy. Panel 2 will assess the implications of Chinese military activities and modernization in 2019 for the United States and U.S. allies and partners. Panel 3 will review the implications of economic, political, and security developments between China and Taiwan for regional security, and explore the escalating situation in Hong Kong.
The hearing will assess China’s role in global health, pharmaceuticals, and medical products. In addition, it will examine the activities of Chinese health and biotech firms in the United States, and U.S. access to China’s health market. Finally, the hearing will consider the implications for U.S. public health and national security of growing U.S. dependence on Chinese health products.